Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Norrett Insider Profile
4 Followers
Kevin Norrett, CBO at Sierra Oncology, holds ― shares in Sierra Oncology (Ticker: SRRA), holds 150.45K shares in Codexis (Ticker: CDXS). Most recently, Kevin Norrett ― shares of Sierra Oncology on ― for an estimated value of ―.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+60.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
COO
Roles that Kevin Norrett holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Norrett
Kevin Norrett's Trading History
Sierra Oncology
―
―
―
―
Codexis
Jan 02, 2024
COO
Uninformative Buy
―
$400.20K
List of latest transactions for each holding click on a transaction to see Kevin Norrett's performance on stock
You May Also Like
Kevin Norrett insider profile FAQ
What is the percentage of profitable transactions made by Kevin Norrett?
The percentage of profitable transactions made by Kevin Norrett is 100%.
What is the average return per transaction made by Kevin Norrett?
The average return per transaction made by Kevin Norrett is 60.70%.
What stocks does Kevin Norrett hold?
Kevin Norrett holds: SRRA, CDXS stocks.
What was Kevin Norrett’s latest transaction?
Kevin Norrett latest transaction was an Uninformative Buy of ―.
What was Kevin Norrett's most profitable transaction?
Kevin Norrett’s most profitable transaction was an Informative Buy of CDXS stock on September 12, 2023. The return on the trade was 61.70%.
What is Kevin Norrett's role in Sierra Oncology?
Kevin Norrett's role in Sierra Oncology is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.